Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × Medulloblastoma × Bevacizumab × Clear all

Phase

Status

Completed 2 Recruiting 1 Not yet recruiting 1 Active not recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Colorectal Neoplasms 27 Carcinoma, Hepatocellular 9 Ovarian Neoplasms 8 Carcinoma, Non-Small-Cell Lung 6 Recurrence 4 Rectal Neoplasms 3 Neoplasm Metastasis 3 Glioblastoma 3 Brain Neoplasms 3 Stomach Neoplasms 2 Liver Neoplasms 2 Endometrial Neoplasms 2 mCRC 1 Uterine Cervical Neoplasms 1 Unresectable Metastatic Colorectal Cancer 1 Spinocerebellar Degenerations 1 Small Cell Lung Carcinoma 1 Rectal Neoplasms Malignant 1 Proteinuria 1 Osteosarcoma 1 Non-small Cell Lung Cancer Patients with Brain Metastases 1 Neutropenia 1 Neoplastic Cells, Circulating 1 Neoplasms, Nerve Tissue 1 Neoplasms 1 Nasopharyngeal Carcinoma 1 NSCLC 1 Metastatic Colorectal Cancer With Left-sided Primary Tumor 1 Medulloblastoma 1 Lung Neoplasms 1

Interventions

Temozolomide 2 fludarabine 1 Vascular Endothelial Growth Factor A 1 Triiodothyronine 1 Nivolumab 1 Irinotecan 1 Histocompatibility Testing 1 Cyclophosphamide 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT07346157 2026-01-16

PNOC044

University of California, San Francisco

Phase 1/2 Not yet recruiting

Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡